Navigation Links
Australia earmarks $74 Million to Fight Bird Flu

Australia has earmarked $74 million to combat the bird flu threat over the next four years.

Prime Minister John Howard was to announce the funding in Busan, Korea, where he is attending the Asia Pacific // Economic Co-operation (APEC) forum.

International agencies, like the World Health Organization (WHO), would get around 20 percent of the money while 10 percent would go on a simulation exercise run by APEC to test the region's preparedness. The bulk will go to the governments of developing members of APEC.

'This is an area where Australia has a strong capacity,'said a statement quoting Howard as saying.

Bird flu has killed 67 of the 130 people it has infected in Asia since 2003.

--IANS
'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
3. Obesity among The Poor in Australia.
4. Increase In Health Insurance Premium Likely In Australia
5. Australian Company Gets $10 million For Developing Skin Cancer Gel
6. Australian Health funds stand accused
7. Bird flu scare in Australia
8. Australia to Show Leniency towards U.S. Pharmaceutical Companies
9. Australia awaits US FDA reports on ADHD drugs
10. No booster vaccine For every fourth child in Australia
11. Australia Witnesses A Fall In the Number of Organ Donors
Post Your Comments:
(Date:9/5/2008)...FRANKLIN, Mass., Sept. 5 /PRNewswire/ -- Arthrosur...eveloper of less-invasive joint,resurfacing system...e U.S.,FDA to begin its pivotal investigation for ...DA stated that "there are no outstanding safety,co...iation., Arthrosurface has been evaluating the sa...
(Date:9/5/2008)...The National Institute of Diabetes and Digestive a...nstitutes of Health (NIH), announces awards to eig...ive studies of urologic chronic pelvic pain disord...rostate. The total research investment for the fiv...ion. , "The launch of this novel research effort...
(Date:9/5/2008)...MIDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturd...e featured on the Oxygen Network show Today,s,Fami...is highlighted as a,leading medical device company...ith effective nebulizers and compressors that deli...ur vision is to improve the lives of those affecte...
(Date:9/5/2008)...ATLANTA, Sept. 5 /PRNewswire/ -- EthicAd, a nonpro...h through consumer education, announces,the launch... public better,understand direct-to-consumer (DTC)..., "Be Smart About Prescription Drug Advertising," ...and Research and was,developed by the FDA in partn...
Breaking Medicine News(10 mins):Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2
...annon Malloy, critically injured in a car accident... tell her story. Doctors call her recovery a mira...Her skull separated from her spine, although her s...ans remained intact. The rare condition is known c...
...raham Lincoln delivered his famous Gettysburg Addr...f smallpox, a new study by two University of Texa... recognized that Lincoln was ill, following his Ge...resident was suffering from a very mild form of sm...
...ed at the National Cancer Institute and Fred Hutch... an antioxidant predominately found in tomatoes , ...fact, the researchers noted an association between...oxidant related to lycopene, and an increased risk...
... the then US President set a target of ten years f...distant dream . "We have learned in that period o...mmunologist Wayne Koff, senior vice president for ...at the International AIDS Vaccine Initiative (IAVI...
Other Medicine News:Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:Study Finds That Lincoln Suffered from Smallpox During Gettysburg Speech 2Health News:Tomatoes are Not So Effective in Preventing Prostate Cancer 2Health News:AIDS Vaccine Still a Long Way Off 2
(Date:9/4/2008)... ,The Lancet, and Presented at ESC Congress-, PHI...new international,study, the GISSI Heart Failure (... acid ethyl esters reduced all cause mortality and... patients with chronic heart,failure. These findin...,The,Lancet, and were presented at the European Ca...
(Date:9/4/2008)...September 4 /- Axentis Pharma AG has,... safety and tolerability,of a new therapeutic form...ction in cystic fibrosis patients. The new formula... delivered directly to the site of,infection. The ... two,different doses of the new drug. Initial resu...
(Date:9/4/2008)...ain on Schedule with Two Abstracts Accepted for ... November 2008, BRIDGEWATER, N.J., Sept. 4 /PRNew...lty pharmaceutical company focused on the treatmen...nnounced the appointment of,Peter L. Garrambone, J...rrambone,s career includes more than 50 pharmaceut...
(Date:9/3/2008)... Rheumatology Research and Education Foundation,s ...nces in Detecting, Treating an... -- For the first time during its,unprecedented in...the,American College of Rheumatology Research and ...acquired from research funded by the Within Our,Re...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Hologic Inc Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies Inc Tender Offer 22765 1Hologic Inc Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies Inc Tender Offer 22765 2SciQuest Announces Newest Life Sciences Customer 3B BioMarin Pharmaceutical Drives Spending Effectiveness with Automated Intuitive Procurement 6211 1SciQuest Announces Newest Life Sciences Customer 3B BioMarin Pharmaceutical Drives Spending Effectiveness with Automated Intuitive Procurement 6211 2Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 1Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 2Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 3Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 4 TraumaCure Receives Prestigious ISO 13485 Certification 6209 1 TraumaCure Receives Prestigious ISO 13485 Certification 6209 2
...econd Multinational Phase III Study Provides Furth...or Inhibition in the Treatment,of Rheumatoid Arthr...nced today that,Toward (1), the second multination...ully reached its primary endpoint and,showed that ...mra,in combination with traditional disease modify...
...First RNA Antagonist Medicine to Be Tested in Pati...gen, 6th June 2007 - Santaris Pharma, the Danish,b...2996, the,Company,s new RNA Antagonist of Bcl-2, h...Phase I/II clinical study in Chronic,Lymphocytic L...rted,this week at the 2007 Annual Meeting of the A...
Other Medicine Technology:New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 2New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 3New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9
Inquire
Inquire
Richardson Blade - for use with Bookler Universal Table Mounted Retractor Systems
...erm being used today to describe the nature of the...ve been used in silicone implants in the early 197...ology cohesive is simply a word thats being used ...the gel. All of Mentor silicone gel-filled breast ...
Medicine Products: